Identification of novel anaplastic lymphoma kinase (ALK) inhibitors using a common feature pharmacophore model derived from known ligands crystallized with ALK.
about
Identification of novel anaplastic lymphoma kinase (ALK) inhibitors using a common feature pharmacophore model derived from known ligands crystallized with ALK.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Identification of novel anapla ...... ligands crystallized with ALK.
@en
Identification of novel anaplastic lymphoma kinase
@nl
type
label
Identification of novel anapla ...... ligands crystallized with ALK.
@en
Identification of novel anaplastic lymphoma kinase
@nl
prefLabel
Identification of novel anapla ...... ligands crystallized with ALK.
@en
Identification of novel anaplastic lymphoma kinase
@nl
P2093
P2860
P356
P1476
Identification of novel anapla ...... ligands crystallized with ALK.
@en
P2093
Huan-Zhang Xie
Sheng-Yong Yang
You-Li Pan
Ze-Rong Wang
P2860
P304
P356
10.1111/CBDD.12084
P577
2012-11-27T00:00:00Z